Abstract
Purpose
The anaplastic thyroid carcinoma (ATC) is the most aggressive thyroid cancer with a high mortality rate. Since nutraceuticals may exert beneficial effects on tumor biology, here, effects of four of these compounds [resveratrol, genistein, curcumin and epigallocatechin-3-gallate (EGCG)] on ATC cell lines were investigated.
Methods
Two ATC-derived cell lines were used: SW1736 and 8505C. Cell viability and in vitro aggressiveness was tested by MTT and soft agar assays. Apoptosis was investigated by Western Blot, using an anti-cleaved-PARP antibody. mRNA and miRNA levels were quantified by real-time PCR.
Results
All tested nutraceuticals caused in both cell lines decrease of cell viability and increase of apoptosis. In contrast, only curcumin reduced in vitro aggressiveness in both SW1736 and 8505C cell lines, while genistein and EGCG determined a reduction of colony formation only in 8505C cells. Effects on genes related to the thyroid-differentiated phenotype were also tested: resveratrol and genistein administration determined the increment of almost all tested mRNAs in both cell lines. Instead curcumin and EGCG treatments had opposite effects in the two cell lines, causing the increment of almost all the mRNAs in 8505C cells and their reduction in SW1736. Finally, effects of nutraceuticals on levels of several miRNAs, known as important in thyroid cancer progression (hsa-miR-221, hsa-miR-222, hsa-miR-21, hsa-miR-146b, hsa-miR-204), were tested. Curcumin induced a strong and significant reduction of all miR analyzed, except for has-miR-204, in both cell lines.
Conclusions
Altogether, our results clearly indicate the anti-cancer proprieties of curcumin, suggesting the promising use of this nutraceutical in ATC treatment. Resveratrol, genistein and EGCG have heterogeneous effects on molecular features of ATC cells.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aggarwal BB, Shishodia S (2006) Molecular targets of dietary agents for prevention and therapy of cancer. Biochem Pharmacol 71:1397–1421. https://doi.org/10.1016/j.bcp.2006.02.009
Allegri L, Baldan F, Mio C, Puppin C, Russo D, Kryštof V, Damante G (2016) Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells. Oncol Rep 35:2413–2418. https://doi.org/10.3892/or.2016.4614
Allegri L, Mio C, Russo D, Filetti S, Baldan F (2017) Effects of HuR downregulation on anaplastic thyroid cancer cells. Oncol lett in press
Asou H, Koshizuka K, Kyo T, Takata N, Kamada N, Koeffier HP (2002) Resveratrol, a natural product derived from grapes, is a new inducer of differentiation in human myeloid leukemias. Int J Hematol 75:528–533
Banerjee S, Li Y, Wang Z, Sarkar FH (2008) Multi-targeted therapy of cancer by genistein. Cancer Lett 269:226–242. https://doi.org/10.1016/j.canlet.2008.03.052
Banno K, Iida M, Yanokura M, Kisu I, Iwata T, Tominaga E, Tanaka K, Aoki D (2014) MicroRNA in cervical cancer: OncomiRs and tumor suppressor miRs in diagnosis and treatment. Sci World J 2014:178075. https://doi.org/10.1155/2014/178075
Borowicz S, Van Scoyk M, Avasarala S, Karuppusamy Rathinam MK, Tauler J, Bikkavilli RK, Winn RA (2014) The soft agar colony formation assay. J Vis Exp JoVE. https://doi.org/10.3791/51998
Braun J, Hoang-Vu C, Dralle H, Hüttelmaier S (2010) Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 29:4237–4244. https://doi.org/10.1038/onc.2010.169
Bulotta S, Celano M, Costante G, Russo D (2016) Emerging strategies for managing differentiated thyroid cancers refractory to radioiodine. Endocrine 52:214–221. https://doi.org/10.1007/s12020-015-0830-4
Cabanillas ME, McFadden DG, Durante C (2016) Thyroid cancer. Lancet Lond Engl 388:2783–2795. https://doi.org/10.1016/S0140-6736(16)30172-6
Celano M, Maggisano V, De Rose RF, Bulotta S, Maiuolo J, Navarra M, Russo D (2015) Flavonoid fraction of citrus reticulata juice reduces proliferation and migration of anaplastic thyroid carcinoma cells. Nutr Cancer 67:1183–1190. https://doi.org/10.1080/01635581.2015.1073760
Celano M, Rosignolo F, Maggisano V, Pecce V, Iannone M, Russo D, Bulotta S (2017) MicroRNAs as biomarkers in thyroid carcinoma. Int J Genomics 2017:1–11. https://doi.org/10.1155/2017/6496570
Chung F-L, Schwartz J, Herzog CR, Yang Y-M (2003) Tea and cancer prevention: studies in animals and humans. J Nutr 133:3268S–3274S
Fassina A, Cappellesso R, Simonato F, Siri M, Ventura L, Tosato F, Busund L-T, Pelizzo MR, Fassan M (2014) A 4-MicroRNA signature can discriminate primary lymphomas from anaplastic carcinomas in thyroid cytology smears. Cancer Cytopathol 122:274–281. https://doi.org/10.1002/cncy.21383
Forte S, Rosa CLA, Pecce V, Rosignolo F, Memeo L (2015) The Role of MicroRNAs in Thyroid Carcinomas. 2048:2037–2047
Gonçalves CFL, de Freitas ML, Ferreira ACF (2017) Flavonoids, thyroid iodide uptake and thyroid cancer—a review. Int J Mol Sci doi. https://doi.org/10.3390/ijms18061247
Gupta S, Hastak K, Afaq F, Ahmad N, Mukhtar H (2004) Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis. Oncogene 23:2507–2522. https://doi.org/10.1038/sj.onc.1207353
Gupta SC, Kim JH, Prasad S, Aggarwal BB (2010) Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29:405–434. https://doi.org/10.1007/s10555-010-9235-2
Haghpanah V, Fallah P, Tavakoli R, Naderi M, Samimi H, Soleimani M, Larijani B (2016) Antisense-miR-21 enhances differentiation/apoptosis and reduces cancer stemness state on anaplastic thyroid cancer. Tumour Biol J Int Soc Oncodev Biol Med 37:1299–1308. https://doi.org/10.1007/s13277-015-3923-z
Karunagaran D, Joseph J, Kumar TRS (2007) Cell growth regulation. Adv Exp Med Biol 595:245–268
Katiyar S, Mukhtar H (1996) Tea in chemoprevention of cancer. Int J Oncol 8:221–238
Kaufman PB, Duke JA, Brielmann H, Boik J, Hoyt JE (1997) A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health. J Altern Complement Med N Y N 3:7–12. https://doi.org/10.1089/acm.1997.3.7
Lazar V, Bidart J-M, Caillou B, Mahé C, Lacroix L, Filetti S, Schlumberger M (1999) Expression of the Na+/I—symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes. J Clin Endocrinol Metab 84:3228–3234. https://doi.org/10.1210/jcem.84.9.5996
Lelli D, Pedone C, Sahebkar A (2017) Curcumin and treatment of melanoma: The potential role of microRNAs. Biomed Pharmacother Biomed Pharmacother 88:832–834. https://doi.org/10.1016/j.biopha.2017.01.078
Li Y, Saldanha SN, Tollefsbol TO (2014) Impact of epigenetic dietary compounds on transgenerational prevention of human diseases. AAPS J 16:27–36. https://doi.org/10.1208/s12248-013-9538-7
Lim YC, Cha YY (2011) Epigallocatechin-3-gallate induces growth inhibition and apoptosis of human anaplastic thyroid carcinoma cells through suppression of EGFR/ERK pathway and cyclin B1/CDK1 complex. J Surg Oncol 104:776–780. https://doi.org/10.1002/jso.21999
Liu L, Wang J, Li X, Ma J, Shi C, Zhu H, Xi Q, Zhang J, Zhao X, Gu M (2015) MiR-204–5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma. Biochem Biophys Res Commun 457:621–626. https://doi.org/10.1016/j.bbrc.2015.01.037
Maggisano V, Celano M, Lombardo GE, Lepore SM, Sponziello M, Rosignolo F, Verrienti A, Baldan F, Puxeddu E, Durante C, Filetti S, Damante G, Russo D, Bulotta S (2017) Silencing of hTERT blocks growth and migration of anaplastic thyroid cancer cells. Mol Cell Endocrinol 448:34–40
Mittal A, Pate MS, Wylie RC, Tollefsbol TO, Katiyar SK (2004) EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis. Int J Oncol 24:703–710
Nakamura Y, Chang C-C, Mori T, Sato K, Ohtsuki K, Upham BL, Trosko JE (2005) Augmentation of differentiation and gap junction function by kaempferol in partially differentiated colon cancer cells. Carcinogenesis 26:665–671. https://doi.org/10.1093/carcin/bgi003
Nikiforova MN, Tseng GC, Steward D, Diorio D, Nikiforov YE (2008) MicroRNA expression profiling of thyroid tumors: biological significance and diagnostic utility. J Clin Endocrinol Metab 93:1600–1608. https://doi.org/10.1210/jc.2007-2696
O’Neill JP, Shaha AR (2013) Anaplastic thyroid cancer. Oral Oncol 49:702–706. https://doi.org/10.1016/j.oraloncology.2013.03.440
Paschka AG, Butler R, Young CY (1998) Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate. Cancer Lett 130:1–7
Pellegriti G, Frasca F, Regalbuto C, Squatrito S, Vigneri R (2013) Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors. J Cancer Epidemiol 2013:e965212. https://doi.org/10.1155/2013/965212
Ros P, Rossi DL, Acebrón A, Santisteban P (1999) Thyroid-specific gene expression in the multi-step process of thyroid carcinogenesis. Biochimie 81:389–396. https://doi.org/10.1016/S0300-9084(99)80086-8
Rosignolo F, Maggisano V, Sponziello M, Celano M, Di Gioia CRT, D’Agostino M, Giacomelli L, Verrienti A, Dima M, Pecce V, Durante C (2015) Reduced expression of THRβ in papillary thyroid carcinomas: relationship with BRAF mutation, aggressiveness and miR expression. J Endocrinol Invest. https://doi.org/10.1007/s40618-015-0309-4
Rosignolo F, Memeo L, Monzani F, Colarossi C, Pecce V, Verrienti A, Durante C, Grani G, Lamartina L, Forte S, Martinetti D, Giuffrida D, Russo D, Basolo F, Filetti S, Sponziello M (2017a) MicroRNA-based molecular classification of papillary thyroid carcinoma. Int J Oncol. https://doi.org/10.3892/ijo.2017.3960
Rosignolo F, Sponziello M, Giacomelli L, Russo D, Pecce V, Biffoni M, Bellantone R, Lombardi CP, Lamartina L, Grani G, Durante C, Filetti S, Verrienti A (2017b) Identification of thyroid-associated serum microRNA profiles and their potential use in thyroid cancer follow-up. J Endocr Soc 1:1–133. https://doi.org/10.1210/JS.2016-1032
Schlumberger M, Lacroix L, Russo D, Filetti S, Bidart J-M (2007) Defects in iodide metabolism in thyroid cancer and implications for the follow-up and treatment of patients. Nat Clin Pract Endocrinol Metab 3:260–269. https://doi.org/10.1038/ncpendmet0449
Schmutzler C, Koehrle J (2000) Innovative strategies for the treatment of thyroid cancer. Eur J Endocrinol 143:15–24
Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR (2008) Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93:4331–4341. https://doi.org/10.1210/jc.2008-1102
Schwertheim S, Wein F, Lennartz K, Worm K, Schmid KW, Sheu-Grabellus S-Y (2017) Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells. J Cancer Res Clin Oncol 143:1143–1154. https://doi.org/10.1007/s00432-017-2380-z
Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle RM, American Thyroid Association Anaplastic Thyroid Cancer Guidelines Taskforce (2012) American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid Off J Am Thyroid Assoc 22:1104–1139. https://doi.org/10.1089/thy.2012.0302
Smith N, Nucera C (2015) Personalized therapy in patients with anaplastic thyroid cancer: targeting genetic and epigenetic alterations. J Clin Endocrinol Metab 100:35–42. https://doi.org/10.1210/jc.2014-2803
Subramaniam D, Ponnurangam S, Ramamoorthy P, Standing D, Battafarano RJ, Anant S, Sharma P (2012) Curcumin induces cell death in esophageal cancer cells through modulating Notch signaling. PloS One 7:e30590. https://doi.org/10.1371/journal.pone.0030590
Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103:2257–2261. https://doi.org/10.1073/pnas.0510565103
Whitlock NC, Baek SJ (2012) The anticancer effects of resveratrol: modulation of transcription factors. Nutr Cancer 64:493–502. https://doi.org/10.1080/01635581.2012.667862
Yao T, Lin Z (2012) MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20. Biochim Biophys Acta 1822:248–260. https://doi.org/10.1016/j.bbadis.2011.09.018
Yin F, Giuliano AE, Van Herle AJ (1999) Growth inhibitory effects of flavonoids in human thyroid cancer cell lines. Thyroid Off J Am Thyroid Assoc 9:369–376. https://doi.org/10.1089/thy.1999.9.369
Yu X-M, Jaskula-Sztul R, Ahmed K, Harrison AD, Kunnimalaiyaan M, Chen H (2013) Resveratrol induces differentiation markers expression in anaplastic thyroid carcinoma via activation of Notch1 signaling and suppresses cell growth. Mol Cancer Ther 12:1276–1287. https://doi.org/10.1158/1535-7163.MCT-12-0841
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This work was supported from MIUR (PRIN 2015, project n° 2015HPMLFY-011) and a grant from Ministero degli Affari Esteri of Italy (Progetti grande rilevanza 2016, project n° PGR02954). FB is supported by an AIRC (Associazione Italiana per la Ricerca sul Cancro) fellowship (Rif. 19,481).
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any study with human or animals performed by the authors.
Informed consent
No human participants were used in this study.
Rights and permissions
About this article
Cite this article
Allegri, L., Rosignolo, F., Mio, C. et al. Effects of nutraceuticals on anaplastic thyroid cancer cells. J Cancer Res Clin Oncol 144, 285–294 (2018). https://doi.org/10.1007/s00432-017-2555-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-017-2555-7